OptimizeRx Corporation

US$8.76As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OPRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 11.74%
Div yield —
ROE 3.68%
Health Information Services
Beta (5Y) 1.15
PE TTM 35.60
TSR TTM (57.25%)
Mkt cap US$165.0M
ROIC 5.91%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.75
(0.12%)
16.74%
Hold 2|10|1|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.20
0.20
0.20
0.23
23.92%
10.73%
8.64%
23.22%
Revenue$M
9.287
9.605
9.644
10.22
15.75%
15.23%
12.64%
16.11%
Peers (US$165.0M)
Cap (US$)
PE
114.2M
—
174.4M
44.71x
Capital
TTM
5Y
10Y
Leveragex
1.868
(0.096)
(0.095)
EBIT/Intx
0.619
1.711
1.292
Own earn%
71.08
7.68
4.24
Sh yield%
39.03
49.04
46.44
Owners
Insiders/Inst%
11.83
54.28
Short interest%
3.04
SBC / revenue%
1.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
27–40
$1 testx
0.0
Incr. ROIC%
17